A recent retrospective analysis of gene expression from human patients [104] to elucidate the contribution of NLR family members in IBD and cancer revealed that NLRP1 was significantly dysregulated; complementary data in Nlrp1b deficient mice confirmed that NLRP1 attenuates GI inflammation and tumorigenesis. This evidence concerns the gene NLRP1 and inflammatory bowel disease.